Veradermics MANE
NYSE MANE
$138.38 +1.98 (+1.45%)
At close: Oct 22, 2026 · 4:00 PM EDT

Veradermics (MANE) Net Shares Issued and Repurchased (2025 - 2026)

Updated

Analysis

Veradermics (MANE) Net Shares Issued and Repurchased (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -9.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -346.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Veradermics 5.78 Bn 4.38 Bn - 442.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 442.70 Mn
Mar 31, 2026 269.11 Mn
Jun 30, 2025 129,000.00
API Access

Veradermics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=MANE&period=max&api_key=YOUR_API_KEY